Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer.
Verco J, Johnston W, Frost M, Baltezor M, Kuehl PJ, Lopez A, Gigliotti A, Belinsky SA, Wolff R, diZerega G. Verco J, et al. Among authors: baltezor m. J Aerosol Med Pulm Drug Deliv. 2019 Oct;32(5):266-277. doi: 10.1089/jamp.2018.1517. Epub 2019 Jul 26. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 31347939 Free PMC article.
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.
Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ. Williamson SK, et al. Among authors: baltezor mj. Cancer Chemother Pharmacol. 2015 May;75(5):1075-87. doi: 10.1007/s00280-015-2737-4. Epub 2015 Apr 23. Cancer Chemother Pharmacol. 2015. PMID: 25898813 Free PMC article. Clinical Trial.
Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies.
Verco S, Maulhardt H, Baltezor M, Williams E, Iacobucci M, Wendt A, Verco J, Marin A, Campbell S, Dorman P, diZerega G. Verco S, et al. Among authors: baltezor m. Drug Deliv Transl Res. 2021 Oct;11(5):1806-1817. doi: 10.1007/s13346-020-00868-4. Epub 2020 Nov 6. Drug Deliv Transl Res. 2021. PMID: 33159289 Free PMC article. Review.
Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies.
Maulhardt H, Verco S, Baltezor M, Marin A, diZerega G. Maulhardt H, et al. Among authors: baltezor m. Drug Deliv Transl Res. 2023 Feb;13(2):503-519. doi: 10.1007/s13346-022-01226-2. Epub 2022 Sep 4. Drug Deliv Transl Res. 2023. PMID: 36058988 Free PMC article. Review.
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies.
diZerega GS, Maulhardt HA, Verco SJ, Marin AM, Baltezor MJ, Mauro SA, Iacobucci MA. diZerega GS, et al. Among authors: baltezor mj. Oncol Ther. 2024 Mar;12(1):31-55. doi: 10.1007/s40487-024-00261-y. Epub 2024 Jan 30. Oncol Ther. 2024. PMID: 38289576 Free PMC article. Review.
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
Weir SJ, Dandawate P, Standing D, Bhattacharyya S, Ramamoorthy P, Rangarajan P, Wood R, Brinker AE, Woolbright BL, Tanol M, Ham T, McCulloch W, Dalton M, Reed GA, Baltezor MJ, Jensen RA, Taylor JA 3rd, Anant S. Weir SJ, et al. Among authors: baltezor mj. Cell Death Dis. 2021 May 31;12(6):562. doi: 10.1038/s41419-021-03836-z. Cell Death Dis. 2021. PMID: 34059639 Free PMC article.
17 results